Bacteria's New Gene Writer Could One Day Fight Aging

Bacteria just revealed a new way to rewrite genetic code, and it could reshape how scientists think about gene writer technology. A team at Columbia University has uncovered a bacterial defense system that protects microbes from viruses by writing fresh strands of DNA from an RNA template, a feat detailed in the journal Nature this month.

The system, known as DRT10 (short for Defense-Associated Reverse Transcriptase 10), works nothing like the CRISPR antiviral defense that scientists uncovered decades ago and later engineered into the world's most famous genome-editing tool. Where CRISPR cuts DNA and base editors swap single genetic letters, this gene writer reads an RNA template and manufactures long stretches of new DNA inside the cell.

Its discoverers stumbled onto the system while hunting through bacterial genomes for enzymes with unknown jobs. Graduate student Stephen Tang, working in the lab of Columbia biochemist Samuel Sternberg, spotted DRT10 inside a large family of DNA-writing enzymes whose functions had been a mystery since the group was catalogued in 2008. Experiments showed the system produces a long piece of repetitive DNA copied from a template RNA, and that this written DNA helps bacteria fend off viral attacks.

How This Gene Writer Differs From CRISPR

The contrast with existing editing tools is stark. CRISPR acts like molecular scissors, snipping DNA at a targeted spot so scientists can delete or insert genes. Base editors take a gentler route, chemically converting one DNA letter into another without cutting the strand. The new gene writer offers a third route: using RNA as a blueprint to build entirely new DNA sequences. As Sternberg put it, the system gives scientists "a different starting point for building tools to engineer cells," as reported by phys.org.

The machinery is unusually exotic. Most genome-editing approaches start with a guide that finds a DNA target and then modify it; DRT10 instead generates new DNA de novo from its RNA template. That manufacturing ability is what makes researchers think the gene writer could become a foundation for therapies that add fresh genetic material to cells rather than merely cutting or patching what is already there. The team even coaxed the enzyme into synthesizing human telomeric DNA repeats inside human cells, according to the Nature paper — an early sign the gene writer can operate beyond its bacterial home.

An Ancient Link to Human Telomerase

The biggest surprise came when Tang realized the bacterial enzyme works much like telomerase, the reverse transcriptase that maintains the protective DNA caps at the ends of human chromosomes. A visiting computational biologist, Mario Rodríguez Mestre of the University of Copenhagen, showed the team an evolutionary tree of all reverse transcriptases: nearly all bacterial enzymes sat on one side, eukaryotic ones on the other — except telomerase, which nestled tightly among the bacterial group. Further analysis supported a shared origin, suggesting the DNA-writing ability arose in a common ancestor before being adapted to maintain linear chromosomes in higher organisms.

That connection reframes a deep question about how complex life began. Linear chromosomes are a hallmark of eukaryotic cells, and they require constant maintenance at their ends. If an ancient relative of this bacterial antiviral defense helped build the first chromosome-end maintenance machinery, as Sternberg suggests, then a system honed for fighting viruses may have helped set the stage for the emergence of higher organisms. The timeline is striking: a defense mechanism shaped by the oldest war on Earth — microbes versus viruses — may share roots with one of the most consequential enzymes in human biology.

Could It Slow Aging or Help Fight Cancer?

The telomerase link points straight at medicine. In humans, telomeres shorten each time a cell divides; when they run out, cells stop dividing and enter a worn-out state called senescence. Accumulating senescent cells is tied to age-related disease, which raises the possibility that rebuilding telomeres could keep cells healthy longer. Sternberg's lab hopes to adapt the bacterial gene writer for telomeropathies — diseases caused by defective telomere maintenance — and is testing whether lengthening chromosomes can delay senescence in human cells. If the gene writer can be adapted to work safely in human cells, it would offer a fundamentally new way to add genetic material rather than cutting or patching existing DNA.

Cancer therapy is another avenue. One potential application is CAR-T treatment, in which a patient's own T cells are engineered to recognize and attack tumors. Keeping those therapeutic cells youthful and active for longer could make the treatment more effective, and the researchers are exploring whether their DNA-writing enzyme could help maintain telomeres in therapeutic T cells. For readers, though, the honest framing matters: this is bench science, not a clinic-ready treatment. Sternberg himself describes the work as being in its "early days," and there are no human trials — turning a bacterial defense enzyme into a safe therapy will take years of further research.

The find is part of a wider hunt for new genetic tools inspired by microbes. Just last month, GenZ NewZ covered a separate discovery: an enzyme found in virus DNA that may also aid gene editing, announced by an artificial intelligence company. That was a company announcement about a preprint; the Columbia work, published in Nature in October 2026, is a peer-reviewed bacterial defense system — a different discovery on a different branch of the same search — one that is quietly turning bacteria into a library of future gene writer tools. For more science coverage, visit the science beat.